Invention Grant
US08647871B2 Endogenous expression of HLA-G and/or HLA-E by mesenchymal cells
有权
通过间充质细胞内源性表达HLA-G和/或HLA-E
- Patent Title: Endogenous expression of HLA-G and/or HLA-E by mesenchymal cells
- Patent Title (中): 通过间充质细胞内源性表达HLA-G和/或HLA-E
-
Application No.: US12532512Application Date: 2008-03-28
-
Publication No.: US08647871B2Publication Date: 2014-02-11
- Inventor: Basil M. Hantash
- Applicant: Basil M. Hantash
- Applicant Address: US CA San Jose
- Assignee: Escape Therapeutics, Inc.
- Current Assignee: Escape Therapeutics, Inc.
- Current Assignee Address: US CA San Jose
- Agency: Wilmer Cutler Pickering Hale and Dorr LLP
- International Application: PCT/US2008/058779 WO 20080328
- International Announcement: WO2008/121894 WO 20081009
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12N5/071 ; C12N5/02
Abstract:
Methods and compositions are provided for the identification and isolation of mammalian HLA-G+ MSC, HLA-E+ MSC, or HLA-G4VHLA-E+ MSC. The methods of the invention provide a means to obtain enriched HLA-G+ MSC, HLA-E+ MSC, or HLA-G+/HLA-E+ MSC populations.
Public/Granted literature
- US20100055785A1 ENDOGENOUS EXPRESSION OF HLA-G AND/OR HLA-E BY MESENCHYMAL CELLS Public/Granted day:2010-03-04
Information query
